Seegene Inc., a global leader in molecular diagnostics, unveiled two new technologies at ADLM 2025 in Chicago (July 29–31) ...

BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced ...

The global healthcare digital twin market is estimated to be approximately US$ 2.1 billion in 2024 and is set to witness a ...

Upgrades to software on Bionano’s Stratys™ Compute, a server that leverages advanced GPU chips, double the number of cancer samples that can be analyzed per week and expand functionality to include ...

Urinary Tract Infection (UTI) and prenatal screening: why do c14.2m UK women still suffer with up to 30% inaccuracy, failed ...

Fellow Health just raised $24 million in a Series B funding round, bringing its cash haul across multiple offerings to $48 ...

Overview of Cell Isolation MarketThe global Cell Isolation Market is valued at USD 15.6 Billion in 2024 and is projected to reach a value of USD 60.56 Billion by 2035 at a CAGR (Compound Annual Growth ...

Notably, the dual therapy group had significantly lower 28-day mortality compared to their monotherapy peers and was ...

The US FDA has conditionally approved TransMedics Group’s IDE to commence the next-generation OCS ENHANCE Heart study.

The global biosimulation market is set for explosive growth, with a new forecast predicting its valuation will increase from ...

Making a clinical diagnosis of dengue, Zika, or chikungunya is notoriously difficult. These arboviral diseases share ...

Discover how AVA brings scale and reproducibility to organ‑chip technology, enabling human‑relevant insights that accelerate ...